MeiraGTx Holdings plc Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down
MeiraGTx Holdings plc (MGTX) reported Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down of $9.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown · last filed 2025-03-13
- MeiraGTx Holdings plc disposal group, not discontinued operation, loss (gain) on write-down for the quarter ending 2024-12-31 was -$409.00K.
- MeiraGTx Holdings plc disposal group, not discontinued operation, loss (gain) on write-down for the quarter ending 2024-09-30 was -$16.00K.
- MeiraGTx Holdings plc disposal group, not discontinued operation, loss (gain) on write-down for the quarter ending 2023-12-31 was -$76.00K.
- MeiraGTx Holdings plc disposal group, not discontinued operation, loss (gain) on write-down for fiscal 2024 was $9.00K, a 30.77% decline from fiscal 2023.
- MeiraGTx Holdings plc disposal group, not discontinued operation, loss (gain) on write-down for fiscal 2023 was $13.00K.
| Period end | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 3 month | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 6 month | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 9 month | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$425.00K derived: sum of 2 quarters · filed 2025-03-13 | $9.00K 10-K · filed 2025-03-13 | |
| 2024-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $418.00K 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | $434.00K 10-Q · filed 2024-08-12 | |||
| 2023-12-31 | -$76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $13.00K 10-K · filed 2025-03-13 | ||
| 2023-09-30 | $89.00K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |